Restasis (cyclosporine ophthalmic emulsion) is a prescription drug that’s used to treat dry eye syndrome. The drug comes as an emulsion (oily liquid). You usually apply 1 drop into each affected eye ...
Yes, people with Medicare Part D who use Restasis may be eligible for a patient assistance program called myAbbVie Assist. This article discusses whether Medicare covers Restasis, Medicare ...
PITTSBURGH, Feb. 3, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received approval from the U.S. Food and Drug Administration ...
Viatris VTRS announced that the FDA has approved the abbreviated new drug application filed by Mylan Pharmaceuticals, a subsidiary of Viatris, which sought approval for a generic version of Restasis ...
Cequa (cyclosporine) and Restasis (cyclosporine) are prescription drugs used to treat chronic (long-term) dry eye. Both drugs come as an eye drop you use twice per day. This article explains the main ...
Americans who are boosted are 95 times less likely than unvaccinated people to die of COVID-19, the FDA approved the first generic drug for Restasis to treat dry eye syndrome, and CMS is putting a ...
Please provide your email address to receive an email when new articles are posted on . They said it would never happen. We would never see it in our lifetimes. It was a dream held by millions, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback